SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001123292-20-000249
Filing Date
2020-02-13
Accepted
2020-02-13 17:05:20
Documents
1
Group Members
RICCARDO BRAGLIA

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A helsinn13ga_02112020.htm SC 13G/A 86528
  Complete submission text file 0001123292-20-000249.txt   88256
Mailing Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Subject) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G/A | Act: 34 | File No.: 005-79594 | Film No.: 20611843
SIC: 2834 Pharmaceutical Preparations

Mailing Address 412F, ROUTE D'ESCH LUXEMBOURG N4 L-2086
Business Address 412F, ROUTE D'ESCH LUXEMBOURG N4 L-2086 003524661113795
Helsinn Investment Fund S.A. SICAR (Filed by) CIK: 0001681851 (see all company filings)

IRS No.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1216
Type: SC 13G/A